Incyte Corporation (NASDAQ:INCY)
over-valued
by 13%
| Website | https://www.incyte.com |
| Sector | Health Care |
| Industry | Biotechnology |
| Fiscal Year End | December |
| Market Cap | $18B |
| Beta | 0.73 |
| Dividends per share | $0.00 |
| Current Price | $79.00 |
| Autochartist™ Valuation | $69.00 |
| Conclusion |
over-valued by -13%
|
